DISSECTING GERMLINE GENETIC MEDIATORS OF CLINICAL RESPONSE TO IMMUNE CHECKPOINT BLOCKADE IN KIDNEY CANCER.

Dana-Farber Cancer Institute, Inc.

Investigators